Nakamura Masafumi, Takatsu Yasuo, Yoshizawa Mutsumi, Yamamura Kenichiro, Miyati Tosiaki
Department of Radiological Technology, Faculty of Health and Welfare, Tokushima Bunri University, 1314-1, Shido, Sanuki-City, Kagawa, 769-2193, Japan.
Division of Health Sciences, Graduate School of Medical Sciences, Kanazawa University, 5-11-80 Kodatsuno, Kanazawa, Ishikawa, 920-0942, Japan.
Radiol Phys Technol. 2025 Mar;18(1):86-93. doi: 10.1007/s12194-024-00858-y. Epub 2024 Nov 7.
In Gd-EOB-DTPA-enhanced MRI, cardiac pulsation artifacts in the left lobe often hinder diagnosis, the image quality need to improve. This study aimed to reduce cardiac pulsation artifacts in Gd-EOB-DTPA-enhanced three-dimensional (3D) T1-weighted turbo-field echo (3D-T1TFE) using compressed sensitivity encoding (CS).For phantom evaluation, the cardiac phantom was manually operated using a metronome-synchronized apparatus, comprising a bag-valve mask, a breathing circuit, and a Jackson-Rees system. Transverse images of a liver phantom were acquired using enhanced T1 high-resolution isotropic volumetric excitation with CS (CS-eTHRIVE) and sensitivity encoding (S-eTHRIVE). For evaluation, images obtained during cardiac phantom operation were subtracted from those obtained when the phantom was stationary. Standard deviation (SD) of the difference images was used as the evaluation metric, and assessments were conducted based on changes in heart rate and TFE factor. For clinical image evaluation, artifacts in hepatobiliary phase images acquired 15 min after Gd-EOB-DTPA injection in the order of S-eTHRIVE and CS-eTHRIVE were visually evaluated at four levels. In heart-rate evaluation (40, 60, and 80 beats/min), CS-eTHRIVE revealed significantly lower SD values compared to S-eTHRIVE across all heart rates (P < 0.01), with no significant differences between heart rates. For TFE factor evaluation, CS-eTHRIVE with a factor of 35 exhibited the lowest SD, which was significantly different from all other groups (P < 0.01). In clinical image evaluation, CS-eTHRIVE achieved higher visual scores (mean ± SD: 3.72 ± 0.46) compared with S-eTHRIVE (2.72 ± 0.98, P < 0.01).CS reduced pulsation artifacts in Gd-EOB-DTPA-enhanced 3D-T1TFE.
在钆塞酸二钠增强磁共振成像(Gd-EOB-DTPA-enhanced MRI)中,左叶的心脏搏动伪影常常妨碍诊断,图像质量有待提高。本研究旨在使用压缩感知编码(CS)减少钆塞酸二钠增强三维(3D)T1加权涡轮场回波(3D-T1TFE)中的心脏搏动伪影。对于体模评估,使用节拍器同步装置手动操作心脏体模,该装置包括袋阀面罩、呼吸回路和杰克逊-里斯系统。使用具有CS的增强型T1高分辨率各向同性容积激发(CS-eTHRIVE)和灵敏度编码(S-eTHRIVE)采集肝脏体模的横向图像。为了进行评估,将心脏体模操作期间获得的图像从体模静止时获得的图像中减去。差异图像的标准差(SD)用作评估指标,并根据心率和TFE因子的变化进行评估。对于临床图像评估,在注射钆塞酸二钠后15分钟采集的肝胆期图像中,按照S-eTHRIVE和CS-eTHRIVE的顺序对伪影进行四级视觉评估。在心率评估(40、60和80次/分钟)中,与S-eTHRIVE相比,CS-eTHRIVE在所有心率下均显示出显著更低的SD值(P < 0.01),心率之间无显著差异。对于TFE因子评估,因子为35的CS-eTHRIVE显示出最低的SD,与所有其他组相比有显著差异(P < 0.01)。在临床图像评估中,与S-eTHRIVE(2.72 ± 0.98,P < 0.01)相比,CS-eTHRIVE获得了更高的视觉评分(平均值 ± SD:3.72 ± 0.46)。CS减少了钆塞酸二钠增强3D-T1TFE中的搏动伪影。